Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
50.9 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash & Cash Equivalents
| 94.819 | 176.21 | 181.095 | 193.705 | 224.947 | 226.672 | 106.773 | 65.997 | 71.66 | 169.489 | 245.363 | 175.01 | 171.332 | 183.801 | 176.735 | 156.179 | 168.129 | 86.329 | 53.135 | 57.952 |
| Short Term Investments
| 196.557 | 140.742 | 142.485 | 104.819 | 2.495 | 20.213 | 71.455 | 135.222 | 145.366 | 57.083 | 0 | 0.291 | 0.483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 291.376 | 316.952 | 323.58 | 298.524 | 227.442 | 246.885 | 178.228 | 201.219 | 217.026 | 226.572 | 245.363 | 175.301 | 171.815 | 183.801 | 176.735 | 156.179 | 168.129 | 86.329 | 53.135 | 57.952 |
| Net Receivables
| 48.059 | 30.304 | 30.841 | 31.361 | 17.714 | 6.37 | 0.246 | 2.918 | 3.582 | 4.012 | 0.62 | 0.323 | 0.092 | 0.139 | 20.157 | 32.199 | 0.02 | 0.001 | 0 | 0 |
| Inventory
| 2.62 | 2.846 | 2.195 | 4.036 | 3.107 | 0.015 | 0 | -0.418 | 0 | -3.995 | 0 | 0 | 4.133 | 0 | 0 | 0 | -0.02 | 0.432 | 0.512 | 0 |
| Other Current Assets
| 14.65 | 7.015 | 5.972 | 6.803 | 7.868 | 12.014 | 10.004 | 4.509 | 4.767 | 3.494 | 8.6 | 6.262 | 4.045 | 6.296 | 8.024 | 3.073 | 2.506 | 2.742 | 1.571 | 0.078 |
| Total Current Assets
| 356.705 | 357.117 | 362.588 | 340.724 | 256.131 | 259.277 | 183.476 | 208.646 | 225.375 | 234.078 | 250.283 | 178.755 | 175.952 | 187.088 | 200.904 | 191.451 | 170.655 | 89.072 | 54.706 | 58.03 |
| Non-Current Assets: | ||||||||||||||||||||
| Property, Plant & Equipment, Net
| 2.866 | 4.195 | 4.21 | 3.47 | 3.348 | 3.625 | 3.678 | 1.733 | 1.532 | 1.647 | 1.776 | 1.841 | 1.829 | 1.709 | 1.021 | 1.173 | 1.236 | 1.363 | 1.395 | 0.28 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 8.567 | 3.667 | 3.767 | 3.867 | 3.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 8.326 | 8.567 | 3.667 | 3.767 | 3.867 | 3.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 3 | 3 | 3 | 0 | 0.631 | 0.21 | 0.322 | 0.306 | 0.371 | 0.157 | 0.169 | 0 | -0.483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0.733 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.094 | 3.421 | 3.379 | 1.317 | 1.514 | 1.253 | 1.451 | 0.529 | 0.585 | 0.583 | 0.6 | 0.887 | 1.609 | 1.615 | 1.525 | 1.33 | 0.081 | 1.75 | 0.138 | 0.006 |
| Total Non-Current Assets
| 20.286 | 19.183 | 14.256 | 8.554 | 10.093 | 9.055 | 5.451 | 2.568 | 2.488 | 2.387 | 2.545 | 2.728 | 2.955 | 3.324 | 2.546 | 2.503 | 1.317 | 3.113 | 1.533 | 0.286 |
| Total Assets
| 376.991 | 376.3 | 376.844 | 349.278 | 266.224 | 268.332 | 188.927 | 211.214 | 227.863 | 236.465 | 252.828 | 181.483 | 178.907 | 190.412 | 203.45 | 193.954 | 171.972 | 92.185 | 56.239 | 58.316 |
| Liabilities & Equity: | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Account Payables
| 27.739 | 26.815 | 26.653 | 19.142 | 18.149 | 10.382 | 8.172 | 7.566 | 5.498 | 5.592 | 4.093 | 3.973 | 2.856 | 2.01 | 3.303 | 4.997 | 2.237 | 4.706 | 1.42 | 0.456 |
| Short Term Debt
| 0.608 | 0.631 | 0.605 | 0.585 | 0.398 | 0.423 | 0.431 | 0.703 | 0.721 | 0.572 | 0.605 | 0.809 | 1.306 | 1.572 | 1.733 | 0.221 | 0.282 | 0.19 | 0.111 | 0.064 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.014 | 0.014 | 0.014 | 0 | 0.055 | 0.055 | 0 | 0.342 | 0.313 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -10.805 | -8.603 | 0 | 0 | -0.572 | 0 | 0 | -4.162 | 0 | 0.342 | 0.313 | 2.11 | 0 | 0 | 0 |
| Other Current Liabilities
| 52.265 | 38.422 | 24.313 | 22.801 | 18.389 | 12.444 | 6.162 | 4.972 | 9.196 | 8.095 | 7.02 | 7.773 | 7.261 | 6.783 | 5.077 | 4.587 | 2.868 | 1.248 | 1.544 | 0.299 |
| Total Current Liabilities
| 80.612 | 65.868 | 51.571 | 42.528 | 36.936 | 23.249 | 14.765 | 13.255 | 15.429 | 14.273 | 11.718 | 12.61 | 11.478 | 10.365 | 10.455 | 10.118 | 5.387 | 6.144 | 3.075 | 0.819 |
| Non-Current Liabilities: | ||||||||||||||||||||
| Long Term Debt
| 71.845 | 71.708 | 71.578 | 29.933 | 31.334 | 29.708 | 24.607 | 24.515 | 19.434 | 19.525 | 19.562 | 19.605 | 0.585 | 0.755 | 0.405 | 0.456 | 0.549 | 0.625 | 0.744 | 0.1 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 1.515 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0.733 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.24 | 1.449 | 1.606 | 0.233 | 1.711 | 1.826 | 0.04 | 0.1 | 0.04 | 0.043 | 0.071 | 0.114 | 0.15 | 0.119 | 0.148 | 0.056 | 0.086 | 0.053 | 63.402 |
| Total Non-Current Liabilities
| 71.845 | 72.948 | 73.027 | 31.539 | 32.3 | 31.419 | 26.433 | 24.555 | 19.534 | 19.565 | 19.605 | 19.676 | 0.699 | 0.905 | 0.524 | 0.604 | 0.605 | 103.87 | 0.797 | 63.502 |
| Total Liabilities
| 152.457 | 138.816 | 124.598 | 74.067 | 69.236 | 54.668 | 41.198 | 37.81 | 34.963 | 33.838 | 31.323 | 32.286 | 12.177 | 11.27 | 10.979 | 10.722 | 5.992 | 110.014 | 3.872 | 64.321 |
| Equity: | ||||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 203.45 | 193.954 | 0 | 3.564 | 0 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.002 | 0.001 | 0.002 |
| Retained Earnings
| -360.21 | -337.097 | -313.677 | -280.387 | -244.656 | -202.754 | -163.606 | -132.182 | -108.763 | -95.164 | -72.653 | -66.91 | -46.672 | -31.821 | -16.124 | -22.469 | -32.845 | -21.379 | -11.241 | -6.034 |
| Accumulated Other Comprehensive Income/Loss
| 0.179 | 0.346 | -0.176 | -0.063 | -0.002 | -0.008 | -0.023 | -0.07 | -0.074 | -0.01 | -0 | 0 | 0 | 0 | -0.266 | -0.142 | 0 | -0.093 | -0.07 | 0 |
| Other Total Stockholders Equity
| 584.559 | 574.229 | 566.093 | 555.655 | 441.641 | 416.421 | 311.353 | 305.651 | 301.732 | 297.796 | 294.153 | 216.103 | 213.398 | 210.959 | 208.591 | 205.697 | 198.821 | 3.471 | 63.607 | 0.027 |
| Total Shareholders Equity
| 224.534 | 237.484 | 252.246 | 275.211 | 196.988 | 213.664 | 147.729 | 173.404 | 192.9 | 202.627 | 221.505 | 149.197 | 166.73 | 179.142 | 192.471 | 183.232 | 165.98 | -17.829 | 52.367 | -6.005 |
| Total Equity
| 224.534 | 237.484 | 252.246 | 275.211 | 196.988 | 213.664 | 147.729 | 173.404 | 192.9 | 202.627 | 221.505 | 149.197 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 376.991 | 376.3 | 376.844 | 349.278 | 266.224 | 268.332 | 188.927 | 211.214 | 227.863 | 236.465 | 252.828 | 181.483 | 178.907 | 190.412 | 203.45 | 193.954 | 171.972 | 92.185 | 56.239 | 58.316 |